| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cytomegalovirus | 9 | 2018 | 600 | 3.92 | Why? |
| DNA, Viral | 10 | 2018 | 2521 | 3.02 | Why? |
| Cytomegalovirus Infections | 8 | 2018 | 667 | 2.85 | Why? |
| Transplantation, Homologous | 9 | 2018 | 757 | 2.11 | Why? |
| Stem Cell Transplantation | 5 | 2017 | 531 | 1.61 | Why? |
| Hematopoietic Stem Cell Transplantation | 9 | 2018 | 2426 | 1.59 | Why? |
| Torque teno virus | 2 | 2018 | 73 | 1.34 | Why? |
| DNA Virus Infections | 2 | 2018 | 88 | 1.33 | Why? |
| Respiratory System | 4 | 2021 | 3213 | 1.11 | Why? |
| Herpesvirus 4, Human | 2 | 2017 | 387 | 1.06 | Why? |
| Viral Load | 9 | 2021 | 15850 | 1.05 | Why? |
| Immunoassay | 6 | 2021 | 4485 | 1.00 | Why? |
| Epstein-Barr Virus Infections | 2 | 2017 | 366 | 0.99 | Why? |
| Vancomycin | 2 | 2016 | 328 | 0.96 | Why? |
| Bacteriological Techniques | 3 | 2018 | 239 | 0.89 | Why? |
| Immunologic Tests | 2 | 2021 | 445 | 0.88 | Why? |
| Glucuronidase | 1 | 2020 | 103 | 0.78 | Why? |
| Staphylococcus aureus | 2 | 2016 | 844 | 0.75 | Why? |
| Water Microbiology | 1 | 2021 | 248 | 0.73 | Why? |
| Gram-Positive Cocci | 1 | 2017 | 20 | 0.72 | Why? |
| Protein Carbonylation | 1 | 2017 | 23 | 0.71 | Why? |
| Viremia | 4 | 2018 | 1020 | 0.71 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2018 | 449 | 0.69 | Why? |
| Meningitis, Viral | 1 | 2018 | 97 | 0.67 | Why? |
| Malondialdehyde | 1 | 2017 | 113 | 0.67 | Why? |
| Viruses | 3 | 2020 | 2238 | 0.67 | Why? |
| Cell Wall | 1 | 2016 | 62 | 0.62 | Why? |
| Cloxacillin | 1 | 2015 | 14 | 0.62 | Why? |
| Staphylococcal Infections | 2 | 2016 | 1099 | 0.61 | Why? |
| Transplantation Conditioning | 1 | 2018 | 323 | 0.61 | Why? |
| Immunoglobulin M | 4 | 2020 | 9091 | 0.61 | Why? |
| Culture Media | 1 | 2017 | 366 | 0.59 | Why? |
| Glutathione | 1 | 2017 | 280 | 0.58 | Why? |
| Phagocytes | 1 | 2016 | 180 | 0.58 | Why? |
| Antibody Affinity | 1 | 2020 | 1078 | 0.58 | Why? |
| Blood Culture | 1 | 2017 | 308 | 0.58 | Why? |
| Nasopharynx | 4 | 2021 | 10224 | 0.56 | Why? |
| Enterobacteriaceae | 1 | 2018 | 395 | 0.53 | Why? |
| Enterovirus Infections | 1 | 2018 | 404 | 0.52 | Why? |
| Plasma | 3 | 2018 | 1809 | 0.51 | Why? |
| Interferon-gamma | 2 | 2021 | 2711 | 0.51 | Why? |
| Asymptomatic Infections | 3 | 2021 | 7218 | 0.50 | Why? |
| Gram-Negative Bacteria | 1 | 2017 | 473 | 0.49 | Why? |
| Organ Transplantation | 2 | 2018 | 2616 | 0.49 | Why? |
| RNA, Viral | 6 | 2021 | 32276 | 0.47 | Why? |
| Immunoglobulin G | 6 | 2021 | 21571 | 0.47 | Why? |
| Transplant Recipients | 6 | 2021 | 4982 | 0.46 | Why? |
| Antigens, Viral | 4 | 2021 | 6298 | 0.46 | Why? |
| Saliva | 2 | 2018 | 4679 | 0.45 | Why? |
| Carrier State | 2 | 2020 | 2100 | 0.44 | Why? |
| Kinetics | 4 | 2021 | 3238 | 0.44 | Why? |
| Molecular Diagnostic Techniques | 2 | 2018 | 4239 | 0.44 | Why? |
| Polymerase Chain Reaction | 3 | 2021 | 6740 | 0.43 | Why? |
| Point-of-Care Testing | 2 | 2021 | 2782 | 0.42 | Why? |
| Antibodies, Viral | 11 | 2021 | 51949 | 0.41 | Why? |
| Endocarditis, Bacterial | 1 | 2015 | 344 | 0.41 | Why? |
| Waste Water | 1 | 2021 | 2185 | 0.40 | Why? |
| Mycobacterium tuberculosis | 2 | 2018 | 1164 | 0.39 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.38 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.38 | Why? |
| Critical Illness | 4 | 2021 | 17281 | 0.37 | Why? |
| Sensitivity and Specificity | 8 | 2021 | 22971 | 0.36 | Why? |
| Proteomics | 2 | 2018 | 2481 | 0.35 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.34 | Why? |
| Aged | 27 | 2021 | 215776 | 0.34 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.33 | Why? |
| Nursing Homes | 2 | 2021 | 4155 | 0.33 | Why? |
| Male | 35 | 2021 | 367725 | 0.33 | Why? |
| Adult | 27 | 2021 | 244371 | 0.32 | Why? |
| Fungal Proteins | 2 | 2018 | 133 | 0.32 | Why? |
| Female | 35 | 2021 | 380317 | 0.32 | Why? |
| Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.32 | Why? |
| Real-Time Polymerase Chain Reaction | 4 | 2018 | 11367 | 0.32 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2021 | 5837 | 0.32 | Why? |
| Reagent Kits, Diagnostic | 3 | 2020 | 2149 | 0.32 | Why? |
| Humans | 56 | 2021 | 930598 | 0.31 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.31 | Why? |
| Middle Aged | 26 | 2021 | 270681 | 0.30 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.30 | Why? |
| Gastrointestinal Microbiome | 2 | 2018 | 1961 | 0.29 | Why? |
| Bacteremia | 1 | 2016 | 1372 | 0.28 | Why? |
| Nose | 2 | 2021 | 1093 | 0.27 | Why? |
| Serologic Tests | 1 | 2018 | 4359 | 0.27 | Why? |
| Anti-Bacterial Agents | 3 | 2017 | 10083 | 0.27 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.24 | Why? |
| Prospective Studies | 10 | 2021 | 43301 | 0.24 | Why? |
| Aged, 80 and over | 11 | 2021 | 88759 | 0.23 | Why? |
| Copper Sulfate | 1 | 2021 | 19 | 0.23 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.23 | Why? |
| Antigens, Bacterial | 1 | 2004 | 330 | 0.22 | Why? |
| Pneumonia, Pneumococcal | 1 | 2004 | 251 | 0.22 | Why? |
| Virus Shedding | 1 | 2018 | 5834 | 0.22 | Why? |
| Sodium Bicarbonate | 1 | 2021 | 54 | 0.22 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.22 | Why? |
| Citric Acid | 1 | 2021 | 116 | 0.21 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.21 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.21 | Why? |
| Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.20 | Why? |
| Antiviral Agents | 6 | 2018 | 41703 | 0.20 | Why? |
| Heart Failure | 2 | 2018 | 6638 | 0.20 | Why? |
| Immunity | 2 | 2021 | 2651 | 0.20 | Why? |
| Green Fluorescent Proteins | 1 | 2020 | 450 | 0.19 | Why? |
| Methane | 1 | 2018 | 26 | 0.19 | Why? |
| Binding Sites, Antibody | 1 | 2020 | 466 | 0.19 | Why? |
| Streptococcus pneumoniae | 1 | 2004 | 827 | 0.19 | Why? |
| Peroxidases | 1 | 2018 | 20 | 0.19 | Why? |
| Trametes | 1 | 2018 | 9 | 0.19 | Why? |
| Darbepoetin alfa | 1 | 2018 | 10 | 0.19 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.19 | Why? |
| Campylobacter | 1 | 2018 | 34 | 0.18 | Why? |
| Preliminary Data | 1 | 2020 | 457 | 0.18 | Why? |
| Hematinics | 1 | 2018 | 48 | 0.18 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.18 | Why? |
| Pycnoporus | 1 | 2017 | 2 | 0.18 | Why? |
| Child | 7 | 2021 | 70012 | 0.18 | Why? |
| Cellulase | 1 | 2017 | 8 | 0.18 | Why? |
| Lignin | 1 | 2017 | 14 | 0.18 | Why? |
| Mycobacterium smegmatis | 1 | 2017 | 27 | 0.17 | Why? |
| Adolescent | 9 | 2021 | 86841 | 0.17 | Why? |
| Hydrogen | 1 | 2018 | 195 | 0.17 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.17 | Why? |
| Hemorrhagic Disorders | 1 | 2017 | 34 | 0.17 | Why? |
| Coloring Agents | 1 | 2018 | 116 | 0.17 | Why? |
| Human bocavirus | 1 | 2017 | 142 | 0.17 | Why? |
| Point-of-Care Systems | 2 | 2021 | 2955 | 0.16 | Why? |
| Respiratory Insufficiency | 1 | 2018 | 7301 | 0.16 | Why? |
| Cellulose | 1 | 2017 | 106 | 0.16 | Why? |
| Itraconazole | 1 | 2018 | 135 | 0.16 | Why? |
| Hemodiafiltration | 1 | 2017 | 65 | 0.16 | Why? |
| Trachea | 1 | 2021 | 894 | 0.16 | Why? |
| Transplants | 1 | 2017 | 136 | 0.16 | Why? |
| Proof of Concept Study | 1 | 2018 | 696 | 0.15 | Why? |
| Echinocandins | 1 | 2017 | 139 | 0.15 | Why? |
| Parvoviridae Infections | 1 | 2017 | 222 | 0.15 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 13720 | 0.15 | Why? |
| Drug Resistance | 1 | 2018 | 395 | 0.15 | Why? |
| Disease Transmission, Infectious | 1 | 2018 | 9044 | 0.14 | Why? |
| Breath Tests | 1 | 2018 | 338 | 0.14 | Why? |
| Myelodysplastic Syndromes | 1 | 2018 | 261 | 0.14 | Why? |
| Fungi | 1 | 2018 | 471 | 0.14 | Why? |
| Cryopreservation | 1 | 2018 | 464 | 0.14 | Why? |
| Microscopy | 1 | 2018 | 414 | 0.14 | Why? |
| Antibiotic Prophylaxis | 1 | 2017 | 399 | 0.14 | Why? |
| Microarray Analysis | 1 | 2016 | 262 | 0.14 | Why? |
| Bronchoalveolar Lavage | 1 | 2018 | 603 | 0.14 | Why? |
| Lipopeptides | 1 | 2017 | 229 | 0.14 | Why? |
| Bacterial Infections | 2 | 2018 | 2229 | 0.13 | Why? |
| Paramyxoviridae Infections | 1 | 2017 | 364 | 0.13 | Why? |
| Biofilms | 1 | 2017 | 304 | 0.13 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.13 | Why? |
| Invasive Fungal Infections | 1 | 2018 | 274 | 0.13 | Why? |
| Hospitals, Community | 1 | 2018 | 475 | 0.13 | Why? |
| Triazoles | 1 | 2018 | 440 | 0.13 | Why? |
| Genotyping Techniques | 1 | 2016 | 360 | 0.13 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.13 | Why? |
| Endocytosis | 1 | 2016 | 451 | 0.12 | Why? |
| DNA | 1 | 2018 | 778 | 0.12 | Why? |
| Microbial Viability | 1 | 2016 | 406 | 0.12 | Why? |
| Water Pollutants, Chemical | 1 | 2018 | 410 | 0.12 | Why? |
| HIV-1 | 2 | 2017 | 3365 | 0.12 | Why? |
| Blood Safety | 1 | 2017 | 459 | 0.12 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.11 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.11 | Why? |
| Antitubercular Agents | 1 | 2018 | 775 | 0.11 | Why? |
| Chromatography | 2 | 2017 | 112 | 0.11 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2018 | 676 | 0.11 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.11 | Why? |
| Lung Diseases | 1 | 2004 | 2361 | 0.11 | Why? |
| Immunocompromised Host | 2 | 2017 | 5150 | 0.11 | Why? |
| Anemia | 1 | 2018 | 789 | 0.10 | Why? |
| Bacteria | 2 | 2018 | 1897 | 0.10 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.10 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2017 | 830 | 0.10 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Ribavirin | 1 | 2017 | 1182 | 0.10 | Why? |
| Infant | 3 | 2021 | 30274 | 0.10 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.10 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.10 | Why? |
| Gene Expression Profiling | 2 | 2018 | 3788 | 0.10 | Why? |
| Rituximab | 1 | 2017 | 1096 | 0.10 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.10 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.09 | Why? |
| Qualitative Research | 1 | 2020 | 4337 | 0.09 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.09 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2017 | 1234 | 0.09 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.08 | Why? |
| Antioxidants | 1 | 2017 | 1593 | 0.08 | Why? |
| Flow Cytometry | 1 | 2016 | 2393 | 0.08 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.08 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.08 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.08 | Why? |
| Microbial Sensitivity Tests | 1 | 2016 | 2886 | 0.08 | Why? |
| Spain | 4 | 2018 | 15545 | 0.08 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.08 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| Liver Transplantation | 1 | 2021 | 2864 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Feces | 1 | 2018 | 4235 | 0.07 | Why? |
| Hematologic Neoplasms | 1 | 2017 | 2105 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.07 | Why? |
| Blood Coagulation Disorders | 1 | 2017 | 2040 | 0.06 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.06 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.06 | Why? |
| HIV Infections | 2 | 2017 | 11620 | 0.05 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.05 | Why? |
| Renal Dialysis | 1 | 2018 | 4358 | 0.05 | Why? |
| Europe | 1 | 2017 | 12702 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.05 | Why? |
| Pneumococcal Infections | 1 | 2004 | 562 | 0.04 | Why? |
| Pectins | 1 | 2017 | 5 | 0.04 | Why? |
| Wood | 1 | 2017 | 29 | 0.04 | Why? |
| Erythropoiesis | 1 | 2018 | 71 | 0.04 | Why? |
| pol Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 39 | 0.04 | Why? |
| Blood-Borne Pathogens | 1 | 2017 | 54 | 0.04 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.04 | Why? |
| HIV Reverse Transcriptase | 1 | 2017 | 104 | 0.04 | Why? |
| HIV Protease | 1 | 2017 | 86 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.04 | Why? |
| Cross Infection | 1 | 2018 | 8675 | 0.04 | Why? |
| Intestine, Small | 1 | 2018 | 336 | 0.04 | Why? |
| Italy | 1 | 2020 | 38444 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2018 | 540 | 0.04 | Why? |
| Reassortant Viruses | 1 | 2017 | 287 | 0.04 | Why? |
| Rifampin | 1 | 2017 | 276 | 0.04 | Why? |
| Exhalation | 1 | 2018 | 441 | 0.04 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.03 | Why? |
| Risk Factors | 3 | 2018 | 71621 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Allografts | 1 | 2017 | 761 | 0.03 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 436 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Geography | 1 | 2018 | 1801 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.03 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2018 | 634 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2017 | 1083 | 0.03 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Polysaccharides | 1 | 2017 | 854 | 0.02 | Why? |
| Lung | 1 | 2018 | 31049 | 0.02 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2018 | 1138 | 0.02 | Why? |
| Coronavirus | 1 | 2017 | 18339 | 0.02 | Why? |
| Homosexuality, Male | 1 | 2017 | 1158 | 0.02 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2017 | 3691 | 0.02 | Why? |
| Disinfection | 1 | 2017 | 2912 | 0.02 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |